Correlation Between Rocket Pharmaceuticals and Acrivon Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Rocket Pharmaceuticals and Acrivon Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Rocket Pharmaceuticals and Acrivon Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Rocket Pharmaceuticals and Acrivon Therapeutics, Common, you can compare the effects of market volatilities on Rocket Pharmaceuticals and Acrivon Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Rocket Pharmaceuticals with a short position of Acrivon Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Rocket Pharmaceuticals and Acrivon Therapeutics,.
Diversification Opportunities for Rocket Pharmaceuticals and Acrivon Therapeutics,
0.5 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Rocket and Acrivon is 0.5. Overlapping area represents the amount of risk that can be diversified away by holding Rocket Pharmaceuticals and Acrivon Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Acrivon Therapeutics, and Rocket Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Rocket Pharmaceuticals are associated (or correlated) with Acrivon Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Acrivon Therapeutics, has no effect on the direction of Rocket Pharmaceuticals i.e., Rocket Pharmaceuticals and Acrivon Therapeutics, go up and down completely randomly.
Pair Corralation between Rocket Pharmaceuticals and Acrivon Therapeutics,
Given the investment horizon of 90 days Rocket Pharmaceuticals is expected to under-perform the Acrivon Therapeutics,. But the stock apears to be less risky and, when comparing its historical volatility, Rocket Pharmaceuticals is 1.62 times less risky than Acrivon Therapeutics,. The stock trades about -0.02 of its potential returns per unit of risk. The Acrivon Therapeutics, Common is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest 1,227 in Acrivon Therapeutics, Common on September 2, 2024 and sell it today you would lose (469.00) from holding Acrivon Therapeutics, Common or give up 38.22% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Rocket Pharmaceuticals vs. Acrivon Therapeutics, Common
Performance |
| Timeline |
| Rocket Pharmaceuticals |
| Acrivon Therapeutics, |
Rocket Pharmaceuticals and Acrivon Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Rocket Pharmaceuticals and Acrivon Therapeutics,
The main advantage of trading using opposite Rocket Pharmaceuticals and Acrivon Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Rocket Pharmaceuticals position performs unexpectedly, Acrivon Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acrivon Therapeutics, will offset losses from the drop in Acrivon Therapeutics,'s long position.| Rocket Pharmaceuticals vs. Uniqure NV | Rocket Pharmaceuticals vs. Rhythm Pharmaceuticals | Rocket Pharmaceuticals vs. Solid Biosciences LLC | Rocket Pharmaceuticals vs. MeiraGTx Holdings PLC |
| Acrivon Therapeutics, vs. Aerovate Therapeutics | Acrivon Therapeutics, vs. Adagene | Acrivon Therapeutics, vs. Rezolute | Acrivon Therapeutics, vs. AN2 Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |